Examination of relation between infliximab blood concentration and the frequency of second failure and effect maintenance after the infliximab secession.

Examination of relation between infliximab blood concentration and the frequency of second failure and effect maintenance after the infliximab secession. - Examination of infliximab blood concentration.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012289

Enrollment

Registered

2013-11-13

Start date

2013-08-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Of this study after having received enough explanation on participating, a document agreement by the free will of the patient person is provided after enough understanding.

Exclusion criteria

Exclusion criteria: It is a patient with the infliximab treatment experience in the past. The patient who judged that a study person in charge or an enforcement partaker was inappropriate.

Design outcomes

Primary

Measure	Time frame
achievement rate of PASI75	—

Countries

Japan

Contacts

Public ContactDaisuke Tsuruta

Osaka city university medical school department of dermatology

dtsuruta@med.osaka-cu.ac.jp06-6645-3826

Outcome results